Taxanes in adjuvant and neoadjuvant therapy for breast cancer
Taxanes (paclitaxel and docetaxel) are currently considered to be basic cytostatics in the treatment of all breast cancer (BC) stages. The results of conducted and ongoing clinical trials suggest that incorporation of taxanes into adjuvant and neoadjuvant chemotherapy regimens enhances the efficienc...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2014-08-01
|
| Series: | Опухоли женской репродуктивной системы |
| Subjects: | |
| Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/263 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849403715068362752 |
|---|---|
| author | S. V. Limareva |
| author_facet | S. V. Limareva |
| author_sort | S. V. Limareva |
| collection | DOAJ |
| description | Taxanes (paclitaxel and docetaxel) are currently considered to be basic cytostatics in the treatment of all breast cancer (BC) stages. The results of conducted and ongoing clinical trials suggest that incorporation of taxanes into adjuvant and neoadjuvant chemotherapy regimens enhances the efficiency of treatment for operable BC and show it necessary to apply an individual approach depending on prognostic and predictive factors. |
| format | Article |
| id | doaj-art-d7d482faecf642dc8c9fd305bce0cb98 |
| institution | Kabale University |
| issn | 1994-4098 1999-8627 |
| language | Russian |
| publishDate | 2014-08-01 |
| publisher | ABV-press |
| record_format | Article |
| series | Опухоли женской репродуктивной системы |
| spelling | doaj-art-d7d482faecf642dc8c9fd305bce0cb982025-08-20T03:37:11ZrusABV-pressОпухоли женской репродуктивной системы1994-40981999-86272014-08-0104152310.17650/1994-4098-2010-0-4-15-23279Taxanes in adjuvant and neoadjuvant therapy for breast cancerS. V. Limareva0Department of Chemotherapy, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowTaxanes (paclitaxel and docetaxel) are currently considered to be basic cytostatics in the treatment of all breast cancer (BC) stages. The results of conducted and ongoing clinical trials suggest that incorporation of taxanes into adjuvant and neoadjuvant chemotherapy regimens enhances the efficiency of treatment for operable BC and show it necessary to apply an individual approach depending on prognostic and predictive factors.https://ojrs.abvpress.ru/ojrs/article/view/263breast canceradjuvant chemotherapytaxanesobjective effectrelapse-free and overall survival |
| spellingShingle | S. V. Limareva Taxanes in adjuvant and neoadjuvant therapy for breast cancer Опухоли женской репродуктивной системы breast cancer adjuvant chemotherapy taxanes objective effect relapse-free and overall survival |
| title | Taxanes in adjuvant and neoadjuvant therapy for breast cancer |
| title_full | Taxanes in adjuvant and neoadjuvant therapy for breast cancer |
| title_fullStr | Taxanes in adjuvant and neoadjuvant therapy for breast cancer |
| title_full_unstemmed | Taxanes in adjuvant and neoadjuvant therapy for breast cancer |
| title_short | Taxanes in adjuvant and neoadjuvant therapy for breast cancer |
| title_sort | taxanes in adjuvant and neoadjuvant therapy for breast cancer |
| topic | breast cancer adjuvant chemotherapy taxanes objective effect relapse-free and overall survival |
| url | https://ojrs.abvpress.ru/ojrs/article/view/263 |
| work_keys_str_mv | AT svlimareva taxanesinadjuvantandneoadjuvanttherapyforbreastcancer |